Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome

Clinical trial NCT05485207 · UNKNOWN

Trial details

NCT number: NCT05485207
Sponsor: Stanford University
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Interstitial Cystitis Bladder Pain Syndrome

Start date: 2022-04-04
Primary completion: 2025-02-28
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.